CLS Holdings USA, Inc. (CLSH)
- Previous Close
0.0299 - Open
0.0299 - Bid 0.0280 x --
- Ask 0.0350 x --
- Day's Range
0.0299 - 0.0350 - 52 Week Range
0.0181 - 0.0650 - Volume
313,216 - Avg. Volume
25,245 - Market Cap (intraday)
5.148M - Beta (5Y Monthly) 1.06
- PE Ratio (TTM)
3.12 - EPS (TTM)
0.0100 - Earnings Date Apr 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, that includes oils, waxes, edibles, and shatters; and provides toll processing services. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. It offers its products under Oasis Cannabis and City Trees brand names. The company's concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.
www.clsholdingsinc.com--
Full Time Employees
May 31
Fiscal Year Ends
Sector
Recent News: CLSH
View MorePerformance Overview: CLSH
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLSH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLSH
View MoreValuation Measures
Market Cap
5.15M
Enterprise Value
9.77M
Trailing P/E
3.12
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.26
Price/Book (mrq)
--
Enterprise Value/Revenue
0.56
Enterprise Value/EBITDA
2.07
Financial Highlights
Profitability and Income Statement
Profit Margin
2.62%
Return on Assets (ttm)
-11.80%
Return on Equity (ttm)
--
Revenue (ttm)
17.54M
Net Income Avi to Common (ttm)
460.24k
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
220.68k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.65M